Effects of magnetic resonance imaging contrast agents on human umbilical vein endothelial cells and evaluation of magnetic resonance imaging contrast media-triggered transforming growth factor-beta induction in dermal fibroblasts (HSF) as a model for nephrogenic systemic fibrosis

Investigative Radiology

Volumn 46, Issue 1, 2011, Pages 71-76

  Wiesinger, Benjamin ^a   Kehlbach, Rainer ^a   Hemsen, Jennifer ^a   Bebin, Julie ^a   Bantleon, Rüdiger ^a   Schwenzer, Nina ^a   Spira, Daniel ^a   Claussen, Claus D ^a   Wiskirchen, Jakub ^b  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b Franziskus Krankenhaus   (Germany)

Author keywords

cell toxicity in vitro; MR contrast media; nephrogenic systemic fibrosis; TGF

Indexed keywords

COLLAGEN; CONTRAST MEDIUM; FERUCARBOTRAN; GADOBENATE DIMEGLUMINE; GADOBUTROL; GADODIAMIDE; GADOLINIUM PENTETATE; MANGAFODIPIR; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CELL PROLIFERATION; CELL VIABILITY; CLONOGENESIS; COLLAGEN SYNTHESIS; COLONY FORMATION; CONTROLLED STUDY; DRUG EFFECT; ENDOTHELIUM CELL; EVALUATION; HUMAN; HUMAN CELL; MACROPHAGE; MONOCYTE; NEPHROGENIC SYSTEMIC FIBROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; SKIN FIBROBLAST;

EID: 78650692173     PISSN: 00209996     EISSN: 15360210     Source Type: Journal    
DOI: 10.1097/RLI.0b013e31820218e9     Document Type: Article

References (36)

1. Ziegert AJ, Blankenbaker DG, De Smet AA, et al. Comparison of standard hip MR arthrographic imaging planes and sequences for detection of arthro-scopically proven labral tear. Am J Roentgenol. 2009;192:1397-1400.
2. Yeh EA, Weinstock-Guttman B, Ramanathan M, et al. Magnetic resonance imaging characteristics of children and adults with pediatric-onset multiple sclerosis. Brain. 2009;132(pt 12):3392-3400.
3. Tanaka YO, Sohda S, Shigemitsu S, et al. High temporal resolution dynamic contrast MRI in a high risk group for placenta accreta. Magn Reson Imaging. 2001;19:635-642.
4. Wittich AC, Salminen ER, Yancey MK, et al. Myomectomy during early pregnancy. Mil Med. 2000;165:162-164.
5. Köken G, Yilmazer M, Sahin FK, et al. Prenatal diagnosis of a fetal intracranial teratoma. Fetal Diagn Ther. 2008;24:368-371.
6. De Santis M, Straface G, Cavaliere AF, et al. Gadolinium periconceptional exposure: pregnancy and neonatal outcome. Acta Obstet Gynecol Scand. 2007;86:99-101.
7. Chen MM, Coakley FV, Kaimal A, et al. Guidelines for computed tomography and magnetic resonance imaging use during pregnancy and lactation. Obstet Gynecol. 2008;112:333-340.
8. Singh AK, Desai H, Novelline RA. Emergency MRI of acute pelvic pain: MR protocol with no oral contrast. Emerg Radiol. 2009;16:133-141.
9. Schieren G, Wirtz N, Altmeyer P, et al. Nephrogenic systemic fibrosis-a rapidly progressing disabling disease with limited therapeutic options. J Am Acad Dermatol. 2009;61:868-874.
10. Schlaudecker JD, Bernheisel CR. Gadolinium-associated nephrogenic systemic fibrosis. Am Fam Physician. 2009;80:711-714.
11. Meran S, Thomas DW, Stephens P, et al. Hyaluronan facilitates transforming growth factor-1-mediated fibroblast proliferation. J Biol Chem. 2008;283: 6530-6545.
12. Lindl T, Lewandowski B, Schreyogg S, et al. An evaluation of the in vitro cytotoxicities of 50 chemicals by using an electrical current exclusion method versus the neutral red uptake and MTT assays. Altern Lab Anim. 2005;33: 591-601.
13. Nicklas AH, Baker ME. Imaging strategies in the pregnant cancer patient. Semin Oncol. 2000;27:623-632.
14. Verswijvel G, Grieten M, Gyselaers W, et al. MRI in the assessment of pregnancy related intrauterine bleeding: a valuable adjunct to ultrasound? JBR-BTR. 2002;85:189-192.
15. Bailey W, Freidenberg GR, James HE, et al. Prenatal diagnosis of a cranio-pharyngioma using ultrasonography and magnetic resonance imaging. Prenat Diagn. 1990;10:623-629.
16. Heinrich MC, Kuhlmann MK, Kohlbacher S, et al. Cytotoxicity of iodinated and gadolinium-based contrast agents in renal tubular cells at angiographic concentrations: in vitro study. Radiology. 2007;242:425-434.
17. Okuda Y, Sagami F, Tirone P, et al. Reproductive and developmental toxicity study of gadobenate dimeglumine formulation (E7155) (3-study of embryo-fetal toxicity in rabbits by intravenous administration. J Toxicol Sci. 1999; 24:79-87. (Pubitemid 30002832)
18. Spencer A, Wilson S, Harpur E. Gadolinium chloride toxicity in the mouse. Hum Exp Toxicol. 1998;17:633-637.
19. Greisberg JK, Wolf JM, Wyman J, et al. Gadolinium inhibits thymidine incorporation and induces apoptosis in chondrocytes. J Orthop Res. 2001;19:797-801.
20. Rofsky NM, Pizzarello DJ, Weinreb JC, et al. Effect on fetal mouse development of exposure to MR imaging and gadopentetate dimeglumine. JMagn Reson Imaging. 1994;4:805-807.
21. Lee ES, Chan J, Shuter B, et al. Microgel iron oxide nanoparticles for tracking human fetal mesenchymal stem cells through magnetic resonance imaging. Stem Cells. 2009;27:1921-1931.
22. Maxwell DJ, Bonde J, Hess DA, et al. Fluorophore-conjugated iron oxide nanoparticle labeling and analysis of engrafting human hematopoietic stem cells. Stem Cells. 2008;26:517-524.
23. Crossgrove J, Zheng W. Manganese toxicity upon overexposure [review]. NMR Biomed. 2004;17:544-553.
24. Grant D, Blazak WF, Brown GL. The reproductive toxicology of intravenously administered MnDPDP in the rat and rabbit. Acta Radiol. 1997;38: 759-769.
25. Wiesinger B, Kehlbach R, Bebin J, et al. Effects of MRI contrast agents on human embryonic lung fibroblasts. Invest Radiol. 2010;45:513-519.
26. Khurana A, Runge VM, Narayanan M, et al. Nephrogenis systemic fibrosis: a review of 6 cases temporally related to gadodiamide injection (omniscan). Invest Radiol. 2007;42:139-145.
27. Rydahl C, Thomsen HS, Marckmann P. High prevalence of nephrogenic systemic fibrosis in chronic renal failure exposed to gadodiamide, a gadolinium-containing magnetic resonance contrast agent. Invest Radiol. 2008;43: 141-144.
28. Hope TA, Herfkens RJ, Denianke KS, et al. Nephrogenic systemic fibrosis in patients with chronic kidney disease who received gadopentetate dimeglumine. Invest Radiol. 2009;44:135-139.
29. Bhagavathula N, DaSilva M, Aslam MN, et al. Regulation of collagen turnover in human skin fibroblasts exposed to a gadolinium-based contrast agent. Invest Radiol. 2009;44:433-439.
30. Edward M, Quinn JA, Mukherjee S, et al. Gadodiamide contrast agents activates fibroblasts: a possible cause of nephrogenic systemic fibrosis. J Pathol. 2008;214:584-593.
31. Varani J, DaSilva M, Warner RL, et al. Effects of gadolinium-based magnetic resonance imaging contrast agents on human skin in organ culture and human skin fibroblasts. Invest Radiol. 2009;44:74-81.
32. Strutz F, Zeisberg M, Renziehausen A, et al. TGF-beta induces proliferation in human renal fibroblasts via induction of basic fibroblast growth factor (FGF-2). Kidney Int. 2001;59:579-592.
33. Meran S, Thomas DW, Stephens P, et al. Hyaluronan facilitates transforming growth factor-beta-1-mediated fibroblast proliferation. J Biol Chem. 2008; 283:6530-6545.
34. Wynn TA. Cellular and molecular mechanisms of fibrosis. J Pathol. 2008; 214:199-210.
35. Wang W, Koka V, Lan HY. Transforming growth factor-beta and Smad signalling in kidney disease. Nephrology. 2005;10:48-56.
36. Wermuth PJ, Del Galdo F, Jimenez SA. Induction of the expression of profibrotic cytokines and growth factors in normal human peripheral blood monocytes by gadolinium contrast agents. Arthritis Rheum. 2009;60:1508-1518.